Instructions for Sustilak (Glucosamine) 60 pills
English product name
Sustilak
Release form
Modified release tablets coated with film sheath
Description Sustilak:
The modified release tablets, coated with a film shell in white or almost white, are oval.
1 tab.
glucosamine hydrochloride 1500 mg
Auxiliary substances:
calcium hydrophosphate - 62 mg,
hypromellose (C200M) - 40 mg,
povidone C90 - 40 mg,
cellulose microcrystalline - 83 mg,
hypromellose (C100M) - 80 mg,
silicon dioxide colloidal - 5 mg, stearic acid - 40 mg.
Shell Composition:
Hypromellose E-5 - 20 mg,
macrogol-6000 - 6 mg,
white opadray OY-58900 (titanium dioxide,
macrogol,
hypromellose) - 11 mg.
15 pcs - box-type contour (4) packages - cardboard packs.
ATC codes
M01AX05 Glucosamine
Clinical-pharmacological groups / Group affiliation
A drug Sustilak that affects metabolism in cartilage. Proteoglycan biosynthesis stimulator
Active substance
glucosamine hydrochloride
Pharmacotherapy group
Tissue regeneration stimulator
Storage Conditions Sustilak
The drug Sustilakshould be stored in a place inaccessible to children, dry, protected from light at a temperature not higher than 25 ° C.
Best before date
Shelf life is 3 years. Do not use after expiry date specified on package.
Pharmacological effect:
Glucosamine helps to prevent cartilage destruction processes, stimulates cartilage tissue regeneration, has anti-inflammatory and analgesic effect, normalizes production of intraarticular fluid. Improves joint mobility and reduces the need for NSAIDs.
Testimony Sustilak:
- osteoarthritis of peripheral joints and spine.
Dosage, Course and Dosage:
The drug Sustilak is taken orally. Tablets are swallowed whole, washed down with water.
The recommended dose is one tablet once a day, for 6-12 weeks. On the recommendation of a doctor, the course of treatment is repeated at intervals of two months. A stable therapeutic effect is achieved when taking the drug Glucosamine for 6 months.
Special instructions
The risk of allergic reactions increases with seafood intolerance.
Influence on the ability to drive vehicles and mechanisms
There are no restrictions on the management of vehicles and complex mechanisms during the period of use of the drug.
Use in renal dysfunction
The drug Glucosamine is contraindicated in severe renal dysfunction.
Terms of implementation
The drug Glucosamine is dispensed without a prescription.
Use in children
The drug Glucosamine is contraindicated in patients under the age of 18 years (efficacy and safety have not been established).
- Nosology Sustilak (ICD codes)
- M15
- Polyarthrosis
- M47
- Spondylosis